logo
  • Offerings
  • Tools & Platforms
  • Markets
  • More

Tata India Pharma & Healthcare Reg Gr

0

0.00(0%)
NAV as of . Log in to view Live prices
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Scheme Information

Logo

Tata India Pharma & Healthcare Reg Gr

as of 26 May 2026, 17:30 PM

Scheme Asset Size₹1325.19 Cr
Expense Ratio1.84%
Cash Holding0.42188%
Fund TypeOpen-End
PlanDividend
BenchmarkNifty Pharma TR INR
Launch Date2015-12-28
Exit LoadExit load of 0.25% for investments if redeemed within 30 Days

SIP Calculator

12%
₹5,000
₹500₹10,00,000
10 Years
1 Year40 Years
Invested Amount
Estimated Return

Invested Amount

₹6,00,000

Est. Return

₹5,61,695

Total Value

₹11,61,695

Invested Amount
Estimated Return
Invest Now

Scheme Ratings

-

rated by Value Research

Scheme Riskometer

Your principal will be at Very High Risk

Investment Returns

Absolute Returns

CAGR

In the last 1 months 7.47%
In the last 3 months 5.11%
In the last 6 months 3.10%
In the last 1 Years 7.20%
In the last 3 Years 0.90%
In the last 5 Years 0.91%

Company Holdings

Company Name
Sector
Instrument
Assets
Sun Pharmaceuticals Industries LtdHealthcareE9.87%
Divi's Laboratories LtdHealthcareE5.92%
HealthCare Global Enterprises LtdHealthcareE5.45%
Abbott India LtdHealthcareE5.37%
Max Healthcare Institute Ltd Ordinary SharesHealthcareE5.17%
Cipla LtdHealthcareE5.07%
Rainbow Childrens Medicare LtdHealthcareE4.23%
Apollo Hospitals Enterprise LtdHealthcareE4.06%
Mankind Pharma LtdHealthcareE3.73%
Dr Reddy's Laboratories LtdHealthcareE3.73%
Fortis Healthcare LtdHealthcareE3.55%
Bayer CropScience LtdBasic MaterialsE3.34%
Metropolis Healthcare LtdHealthcareE3.07%
Syngene International LtdHealthcareE2.94%
Lupin LtdHealthcareE2.94%
Sai Life Sciences LtdHealthcareE2.63%
Dr. Lal PathLabs LtdHealthcareE2.60%
Alkem Laboratories LtdHealthcareE2.49%
GlaxoSmithKline Pharmaceuticals LtdHealthcareE2.44%
Neuland Laboratories LtdHealthcareE2.41%
J.B. Chemicals & Pharmaceuticals LtdHealthcareE2.21%
Global Health LtdHealthcareE2.16%
FDC LtdHealthcareE1.94%
Ajanta Pharma LtdHealthcareE1.90%
Vijaya Diagnostic Centre LtdHealthcareE1.72%
Sanofi India LtdHealthcareE1.68%
Procter & Gamble Health LtdHealthcareE1.55%
Torrent Pharmaceuticals LtdHealthcareE1.01%
Corona Remedies LtdHealthcareE0.77%
Tata Chemicals LtdBasic MaterialsE0.72%
PI Industries LtdBasic MaterialsE0.70%
Aurobindo Pharma LtdHealthcareE0.70%
HDFC Life Insurance Co LtdFinancial ServicesE0.67%
Sumitomo Chemical India Ltd Ordinary SharesBasic MaterialsE0.43%
Jubilant Pharmova LtdHealthcareE0.36%
Dr Agarwal’s Health Care LtdHealthcareE0.07%
Ipca Laboratories LtdHealthcareE0.00288%
A) Repo-CR0.22%
Cash / Net Current Asset-C0.20%
Krishna Institute of Medical Sciences Ltd-E-

Sector Holding Analysis

Equity / Debt / Cash Split

Loading chart…

Equity

99.58%

Cash

0.42%

Equity sector allocation

Loading chart…

Basic Materials

5.19%

Financial Services

0.67%

Healthcare

93.72%

Others

0.42%

Fund House Contact Details

Websitewww.tatamutualfund.com
Phone+91 22 6657 8282
Logo
Tata Asset Management Pvt Ltd

Asset Management Company

About Tata India Pharma & Healthcare Reg Gr

Investment Objective of the Scheme

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Key Features of The Fund

5-year return

+13.81%

Fund Manager

Rajat Srivastava

Risk Profile

Very High Risk

Expense Ratio

1.84%

Fund Size

₹1325.19 Cr

FAQ's

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy